Welcome to our dedicated page for Medifast news (Ticker: MED), a resource for investors and traders seeking the latest updates and insights on Medifast stock.
Medifast, Inc. reports developments as a metabolic health and wellness company built around the OPTAVIA science-backed, coach-guided lifestyle system. Its updates center on revenue trends, gross margin, active earning coaches, coach productivity and the company's shift toward metabolic health amid changes in weight-loss demand and GLP-1 medication adoption.
Recurring company news also covers OPTAVIA program evidence, nutrition and habit-creation offerings, HSA/FSA reimbursement availability on select insurance plans, independent coach community initiatives, media content tied to metabolic health, and governance matters such as board nominations and stockholder cooperation agreements.
Medifast, Inc. (NYSE: MED) plans to release its financial results for Q2 2020, ending June 30, on August 5, 2020, after market close. The announcement will be followed by a conference call at 4:30 p.m. ET to discuss the results, featuring CEO Dan Chard and CFO Jim Maloney. The call can be accessed live on Medifast's investor relations website, with an archived version available until August 19, 2020. The results will shed light on the company’s performance and growth strategies impacted by its expanding health and wellness community, OPTAVIA®.
Medifast, Inc. (NYSE: MED) has appointed Jim Maloney as the new Chief Financial Officer, effective July 20, 2020. Maloney will oversee financial planning, capital allocation strategies, and investor relations. His extensive background includes leadership roles at L.B. Foster and H.J. Heinz, where he focused on financial management and building value. CEO Dan Chard stated that Maloney's experience will support Medifast's mission of delivering sustainable growth through its OPTAVIA® community, which promotes lifelong healthy habits.
Summary not available.
Medifast, Inc. (NYSE: MED) has declared a quarterly cash dividend of $1.13 per share, payable on August 6, 2020, to stockholders of record by June 30, 2020. The company aims to continue its quarterly dividend program, although future declarations are subject to the Board of Directors' discretion based on relevant factors. Medifast is recognized for its OPTAVIA® health and wellness community, which focuses on sustainable healthy habits and has seen significant growth.